Connect with us

Market research

Shingles Vaccine market is projected to witness an absolute dollar opportunity growth of US$ 10.2 Bn during 2022-2032

Avatar

Published

on

The shingles vaccine market refers to the segment of the pharmaceutical industry that offers vaccines for the prevention of herpes zoster, commonly known as shingles. Shingle is a viral infection caused by the reactivation of the varicella-zoster virus (VZV), which causes chickenpox. The shingles vaccine helps to reduce the risk of developing shingles and postherpetic neuralgia (PHN), a complication of shingles that can cause chronic pain.

The global Shingles Vaccine market was valued at around US$ 3.5 Bn in 2021. With a projected CAGR of 13.9% for the next ten years, the market is likely to reach a valuation of nearly US$ 14.1 Bn by the end of 2032. The Global Shingles Vaccine market is projected to witness an absolute dollar opportunity growth of US$ 10.2 Bn during 2022-2032.

Request For Free Sample Report of “Shingles Vaccine Market”https://www.persistencemarketresearch.com/samples/33198

The global shingles vaccine market is driven by several factors, including the increasing prevalence of shingles, the growing aging population, and the increasing awareness of the importance of vaccination. The market is also driven by the availability of multiple effective vaccines, such as Zostavax and Shingrix, which are approved for use in various countries.

The shingles vaccine market is segmented based on product type, distribution channel, and geography. The product type segment includes live attenuated vaccines and subunit vaccines. The distribution channel segment includes hospitals, clinics, pharmacies, and online sales. The hospital segment dominates the market due to the availability of skilled healthcare professionals and the presence of advanced healthcare infrastructure.

 Companies

  • GlaxoSmithKline plc.
  • Merck & Co., Inc.
  • SK Chemicals
  • Green Cross Corp
  • Geneone Life Science
  • Vaccitech
  • CanSinoBIO
  • Cipla Inc.
  • Pfizer Inc

 Buy the Full Report Now @ https://www.persistencemarketresearch.com/checkout/33198

North America is the largest market for shingles vaccines, primarily due to the high prevalence of shingles in the region, the growing aging population, and the availability of advanced healthcare infrastructure. Europe is the second-largest market for shingles vaccines, followed by the Asia Pacific region. The Asia Pacific region is expected to experience significant growth in the coming years due to the increasing awareness of the importance of vaccination, the growing aging population, and the rising healthcare expenditure.

The major players in the shingles vaccine market include GlaxoSmithKline, Merck & Co., Sanofi Pasteur, CSL Limited, and Novartis International AG, among others. These companies are primarily focused on research and development activities to develop more effective vaccines and expand their presence in emerging markets.

In conclusion, the shingles vaccine market is driven by several factors, including the increasing prevalence of shingles, the growing aging population, and the increasing awareness of the importance of vaccination. The market is segmented based on product type, distribution channel, and geography, and is dominated by North America. The major players in the market are focused on research and development activities to develop more effective vaccines and expand their presence in emerging markets.

 Request Customization @ https://www.persistencemarketresearch.com/request-customization/33198

Advertisement
interviews-reviews

Key Segments Covered in Shingles Vaccine Industry Survey

Shingles Vaccine Market by Product type:

  • Shingles
  • Zostavax
  • Sky Zoster

Shingles Vaccine Market by Vaccine type:

  • Recombinant Vaccine
  • Live Attenuated Vaccine

Shingles Vaccine Market by Region:

  • North America Shingles Vaccine Market
  • Latin America Shingles Vaccine Market
  • Europe Shingles Vaccine Market
  • South Asia Shingles Vaccine Market
  • East Asia Shingles Vaccine Market
  • Oceania Shingles Vaccine Market
  • Middle East & Africa Shingles Vaccine Market

 For More Premium Insights, Check out the Link:

Hearing Aids Market

Endodontics And Orthodontics Market

Wound Healing Assessment Market

Liquid Embolic Market

North America Vet Compounding Pharmacies Market

Car T Cell Therapy Market

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, semiconductors and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

Advertisement
interviews-reviews

Contact Us:

Persistence Market Research

United States

Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States

U.S. Ph. – +1-646-568-7751

USA-Canada Toll-free – +1 800-961-0353

Sales – [email protected]

Continue Reading
Comments
Advertisement Submit

TechAnnouncer On Facebook

Pin It on Pinterest

Share This